TechnologyPatent OppositionCompetitive Analysis

In the competitive field of Protein And Peptide Compounds, companies are constantly innovating to stay ahead. Discover the latest patent opposition trends, top opposing and opposed companies, and the most recent patents getting opposed. Stay informed on the latest developments in Protein And Peptide Compounds technology and learn how to protect your intellectual property.

Get Patent Opposition Report for Protein And Peptide Compounds

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Download Industry Landscape Report

Explore the top companies that have filed the most patent oppositions in the technology industry.

Explore the top companies that have faced the most patent oppositions in the technology industry.

Explore the top law firms that have filed the most patent oppositions in the technology industry.

Patent challenges are becoming increasingly common in the Protein And Peptide Compounds industry as companies work to protect their innovations in a highly competitive market. These legal battles can significantly impact the development and release of new technologies. Below is a list of the latest patents that have been opposed in the Protein And Peptide Compounds industry, offering a snapshot of the ongoing struggles over intellectual property rights. For anyone involved in this industry, understanding these patent disputes is essential for navigating its future.

Last updated on: Jul 31, 2025
Patent NumberTitleApplicantOpposition DateOpposition Name

Get alerts on new patent oppositions in the Protein And Peptide Compounds industry

Antibodies With Modified Affinity To Fcrn That Promote Antigen ClearanceCHUGAI SEIYAKU KABUSHIKI KAISHAJun 25, 2025STRAWMAN
Methods For Reducing Lipoprotein(A) Levels By Administering An Inhibitor Of Proprotein Convertase Subtilisin Kexin-9 (Pcsk9)REGENERON PHARMACEUTICALSJun 23, 2025AMGEN
Method Of Treating Or Ameliorating Metabolic Disorders Using Glp-1 Receptor Agonists Conjugated To Antagonists For Gastric Inhibitory Peptide Receptor (Gipr)AMGENJun 18, 2025JG OPPOSITIONS
Anti-Pd-1 And Anti-Vegfa Bifunctional Antibody, Pharmaceutical Composition Thereof And Use ThereofAKESO BIOPHARMAJun 18, 2025STRAWMAN
Uses For And Article Of Manufacture Including Her2 Dimerization Inhibitor PertuzumabF HOFFMANN LA ROCHEJun 18, 2025BRAND MURRAY FULLER
Method Of Treating Or Ameliorating Metabolic Disorders Using Glp-1 Receptor Agonists Conjugated To Antagonists For Gastric Inhibitory Peptide Receptor (Gipr)AMGENJun 17, 2025CAMULON
Uses For And Article Of Manufacture Including Her2 Dimerization Inhibitor PertuzumabF HOFFMANN LA ROCHEJun 17, 2025LANYON OPPOSITIONS
Method Of Treating Or Ameliorating Metabolic Disorders Using Glp-1 Receptor Agonists Conjugated To Antagonists For Gastric Inhibitory Peptide Receptor (Gipr)AMGENJun 16, 2025BOULT WADE TENNANT
Interleukin-31 Monoclonal AntibodyZOETIS SERVICESJun 16, 2025MARGARET DIXON
Interleukin-31 Monoclonal AntibodyZOETIS SERVICESJun 13, 2025BOEHRINGER INGELHEIM VETMEDICA

To stay ahead in the competitive Protein And Peptide Compounds industry, companies are constantly innovating. Here are the top patents facing oppositions in the Protein And Peptide Compounds industry. Stay informed on the latest opposition trends and learn how to protect your intellectual property.

Last updated on: Jul 31, 2025
Patent NumberGrant DateTitleApplicantTotal Oppositions
Nov 1, 2017Prevention Of Disulfide Bond Reduction During Recombinant Production Of PolypeptidesGENENTECH11
Jan 10, 2018Method To Improve Virus Removal In Protein PurificationF HOFFMANN LA ROCHE11
Nov 21, 2018Formulation Of Boronic Acid CompoundsTHE UNITED STATES OF AMERICA11
Mar 2, 2022Modified Nucleoside, Nucleotide, And Nucleic Acid CompositionsMODERNATX10
Sep 19, 2018Methods Of Cell CultureMOMENTA PHARMACEUTICALS10
Feb 17, 2021Pharmaceutical Composition For Cancer TreatmentSHIONOGI10
May 15, 2019Combination Therapy For The Treatment Of Ovarian CancerFHOFFMANN LA ROCHE10
Feb 17, 2021Subcutaneously Administered Bispecific Antibodies For Use In The Treatment Of CancerLINDIS BIOTECH10
Nov 29, 2017Prevention Of Disulfide Bond Reduction During Recombinant Production Of PolypeptidesGENENTECH9
May 15, 2019Uses For And Article Of Manufacture Including Her2 Dimerization Inhibitor PertuzumabFHOFFMANN LA ROCHE9